Glenmark launches NINDANIB (nintedanib) for pulmonary fibrosis in India
Two clinical trials are being rolled out to study the efficacy and safety of Nintedanib as a treatment of SARS-COV2 induced…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
lung diseases
Lupin opens centre of excellence for inhalation research in Florida
The new facility will focus on the R&D of inhalation products for the treatment of asthma, allergic rhinitis, chronic…